Benedetta Casamento was elected as Executive Chairman at MILESTONE SCIENTIFIC INC..
“electing Ms. Casamento as Executive Chairman.”
MILESTONE SCIENTIFIC INC. — fact timeline
Source-grounded facts extracted from MILESTONE SCIENTIFIC INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Greg Shilling was appointed as Independent Director at MILESTONE SCIENTIFIC INC..
“On June 19, 2026, the Board of Directors of the Company unanimously appointed, by the directors in attendance, Kelly Ulto and Greg Shilling as independent directors of the Company.”
Kelly Ulto was appointed as Independent Director at MILESTONE SCIENTIFIC INC..
“On June 19, 2026, the Board of Directors of the Company unanimously appointed, by the directors in attendance, Kelly Ulto and Greg Shilling as independent directors of the Company.”
Shanth Thiyagalingam departed as Director at MILESTONE SCIENTIFIC INC..
“Shanth Thiyagalingam, a member of the Board of Directors (the “Board”) since 2025, was nominated to continue as a director but has advised the Company that he has decided to devote his full time as chief executive officer of PainTEQ and to his family, and not to run for re-election.”
MILESTONE SCIENTIFIC INC. engaged Grassi & Co., CPAs, P.C. as its auditor.
“The Company engaged Grassi & Co., CPAs, P.C. to be the independent registered public accounting firm to the Company for”
MILESTONE SCIENTIFIC INC. dismissed CBIZ CPAs P.C. as its auditor.
“(the “Company”) approved the dismissal of CBIZ CPAs P.C. (“CBIZ CPAs”) as the independent registered public accounting firm to the Company effective as of May 15,”
MILESTONE SCIENTIFIC INC. issued 7,962,963 units of unit to the purchasers named therein for $0.27 per unit.
“the private placement (the “Private Placement”) of an aggregate of 7,962,963 units (the “Units”), with each Unit consisting of (i) one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) one warrant to purchase one share of Common Stock (each, a “Warrant”). The purchase price paid by the Purchasers for each Unit is $0.27 (the “Per Unit Purchase Price”).”
MILESTONE SCIENTIFIC INC. entered into Purchase Agreement with the purchasers named therein (the "Purchasers") valued at $2,150,000 (effective 2026-04-20).
“On April 20, 2026, Milestone Scientific Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of an aggregate of 7,962,963 units (the “Units”), with each Unit consisting of (i) one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) one warrant to purchase one share of Common Stock (each, a “Warrant”).”
MILESTONE SCIENTIFIC INC. amended Amendment with Innovest S.p.A. (effective 2026-03-31).
“On March 31, 2026, Milestone Scientific Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Amended and Restated Memorandum of Understanding, dated January 13, 2026 (the “MOU”), with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation (“BP4”).”
MILESTONE SCIENTIFIC INC.: The Company amended its Restated Certificate of Incorporation to increase authorized shares of common stock from 100,000,000 to 125,000,000 (effective 2026-03-10).
“As a result of the stockholder approval, the Company filed a Certificate of Amendment of its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on March 10, 2026, which amendment became effective on filing.”
MILESTONE SCIENTIFIC INC. entered into Amended and Restated Memorandum of Understanding with Innovest S.p.A. (effective 2026-01-15).
“On January 15, 2026, Milestone Scientific Inc. (“the Company”) entered into an Amended and Restated Memorandum of Understanding (the “MOU”) with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation (“BP4”).”
MILESTONE SCIENTIFIC INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).
“October 8, 2025, Milestone Scientific Inc. (“the Company”) received a letter from NYSE American LLC (“NYSE American” or the “Exchange”) stating that the Company is not in compliance with the continued listing standards as outlined in Section(s) 1003(a)(ii), and (iii) of the NYSE American Company Guide (the “Company Guide”). To maintain its listing, the Company must submit a plan of compliance by November 7, 2025, outlining the actions it has taken or will take to regain compliance. If the plan is accepted, the Company may be able to continue its listing but will be subject to periodic reviews”
Shanth Thiyagalingam was appointed as independent director at MILESTONE SCIENTIFIC INC..
“On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company.”
MILESTONE SCIENTIFIC INC. engaged CBIZ CPAs P.C. as its auditor.
“CBIZ CPAs was engaged to serve as the independent registered public accounting firm”
Marcum LLP resigned as auditor of MILESTONE SCIENTIFIC INC..
“od for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Item 4.01 Changes in Registrant ’ s Certifying Accountant Based on information provided by Marcum LLP ("Marcum"), the independent registered public accounting firm of Milestone Scientific Inc. (the "Company"), CBIZ CPAs P.C. ("CBIZ CPAs") acquired the attest business of Marcum, effective November 1, 2024. Marcum continued to serve as the Company's independent registered public accounting firm through April 22, 2025. On April 22, 2025, Marcum resigned as the Company's independent registered public accounting firm, and CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025, effective immediately.”
Giandomenico Trombetta resigned as Director at MILESTONE SCIENTIFIC INC..
“On January 12, 2025, Mr. Giandomenico Trombetta, a director of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he is resigning, effective immediately, as a director.”
Neal Goldman was appointed as Interim Chief Executive Officer at MILESTONE SCIENTIFIC INC..
“Mr. Neal Goldman, the Chairman of the Board of Directors of the Company, has been appointed the Interim Chief Executive Officer, effective on Mr. Haverhals retirement.”
Arjan Haverhals departed as Chief Executive Officer at MILESTONE SCIENTIFIC INC..
“On November 8, 2024, Mr. Arjan Haverhals, the Chief Executive Officer of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he intends to retire as an officer from the Company upon the expiration of, and not seek the renewal of, his employment agreement, on December 31, 2024.”
MILESTONE SCIENTIFIC INC. entered into Underwriting Agreement with Maxim Group LLC (effective 2023-12-10).
“On December 10, 2023, Milestone Scientific Inc. (the "Company") entered into an Underwriting Agreement (the "Underwriting Agreement") with Maxim Group LLC, acting as sole underwriter and book-running manager (the "Underwriter"), for a public offering (the "Offering") of an aggregate of 4,765,000 shares of common stock, par value $0.001 per share (the "Common Stock") of the Company.”
Dr. Didier Demesmin was appointed as independent director at MILESTONE SCIENTIFIC INC..
“On September 6, 2023, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Dr. Didier Demesmin as an independent director of the Company.”
Peter J. Milligan resigned as Chief Financial Officer at MILESTONE SCIENTIFIC INC..
“On August 24, 2023, Milestone Scientific Inc. (the “Company”) announced that Peter J. Milligan, the Company’s part-time Chief Financial Officer, resigned effective September 1, 2023.”
MILESTONE SCIENTIFIC INC. shareholders approved Ratified the appointment of Marcum LLP as the Company’s independent auditors for the fiscal year ending December 31, 2023 at the 2023-06-28 meeting.
“Proposal 3 Shares For Shares Against Shares Abstaining Broker Non-Votes Ratified the appointment of Marcum LLP as the Company’s independent auditors for the fiscal year ending December 31, 2023 35,032,393 122,150 119,506 --”
MILESTONE SCIENTIFIC INC. shareholders approved Approval of an amendment to the Company’s 2020 Equity Inventive Plan to increase the number of shares of Common Stock which may be issued from 4,000,000 to 11,500,000 at the 2023-06-28 meeting.
“Proposal 2 Shares For Shares Against Shares Abstaining Broker Non-Votes Approval of an amendment to the Company’s 2020 Equity Inventive Plan 13,612,094 4,397,541 227,343 17,037,071”
MILESTONE SCIENTIFIC INC. shareholders approved Election of six incumbent directors to serve until the next annual meeting of the Company’s stockholders or until their respective successors have been duly elected and qualified at the 2023-06-28 meeting.
“Proposal 1 Election of Directors Shares For Shares Withheld Broker Non-Votes Neal Goldman 15,252,970 2,984,008 17,037,071 Leonard Osser 14,957,157 3,279,821 17,037,071 Benedetta I. Casamento 15,136,752 3,100,226 17,037,071 Michael McGeehan 15,154,569 3,082,409 17,037,071 Gian Domenico Trombetta 14,991,975 3,245,003 17,037,071 Arjan Haverhals 15,122,302 3,114,676 17,037,071”
Peter Milligan was appointed as Chief Financial Officer at MILESTONE SCIENTIFIC INC..
“On February 6, 2023, Milestone Scientific Inc. (the “Company”) announced the appointment of Peter Milligan as the Company’s Chief Financial Officer, on a part-time basis, effective February1, 2023.”
Arjan Haverhals was appointed as Director at MILESTONE SCIENTIFIC INC..
“the Board unanimously appointed Arjan Haverhals as a director of the Company.”
Neal Goldman was appointed as Chairman of the Board at MILESTONE SCIENTIFIC INC..
“the Company's Board of Directors (the "Board") unanimously appointed Neal Goldman, who has been a member of the Board since 2019, as Chairman of the Board.”
Leslie Bernhard resigned as Chairman of the Board, Director, Chairman of the Audit Committee at MILESTONE SCIENTIFIC INC..
“On January 4, 2023, Leslie Bernhard tendered her resignation to Milestone Scientific Inc. (the "Company") as a director, Chairman of the Audit Committee and Chairman of the Board of the Company.”
Leonard M. Schiller resigned as Director at MILESTONE SCIENTIFIC INC..
“On December 5, 2022, Leonard M. Schiller tendered his resignation to Milestone Scientific Inc. (the “Company”) as a director of the Company.”
Benedetta Casamento was appointed as Director at MILESTONE SCIENTIFIC INC..
“On April 27, 2022, Milestone Scientific Inc. (the “Company”) announced the appointment of Benedetta Casamento to the Company’s Board of Directors.”
Scott Kahn departed as Chief Financial Officer at MILESTONE SCIENTIFIC INC..
“On July 2, 2021, Milestone Scientific Inc. (the “Company”) announced that Scott Kahn, the Company’s Chief Financial Officer, and the Company have reached a mutual decision to part ways.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.